Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joel Sheinfeld

Showing results (41-50 of 115) with videos related to

Pageof 12
Sort By:
The Journal of Urology|July 9, 2016
Retroperitoneal Lymph Node Dissection: Anatomical and Technical Considerations from a Cadaveric StudyTyler S Beveridge, Brian L Allman, Marjorie Johnson, et al.
The Journal of Urology|July 12, 2005
Retroperitoneal lymph node dissection in patients with low stage testicular cancer with embryonal carcinoma predominance and/or lymphovascular invasionAndrew J Stephenson, George J Bosl, Dean F Bajorin, et al.
Urology|October 11, 2003
Reoperative retroperitoneal surgery for nonseminomatous germ cell tumor: clinical presentation, patterns of recurrence, and outcomeJames M McKiernan, Robert J Motzer, Dean F Bajorin, et al.
Cancer|December 21, 2006
Pathologic findings and clinical outcome of patients undergoing retroperitoneal lymph node dissection after multiple chemotherapy regimens for metastatic testicular germ cell tumorsScott E Eggener, Brett S Carver, Stacy Loeb, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 20, 2005
Etoposide and cisplatin chemotherapy for metastatic good-risk germ cell tumorsG Varuni Kondagunta, Jennifer Bacik, Dean Bajorin, et al.
Urology|May 29, 2016
Pelvic Lymph Node Dissection in Patients Treated for Testis Cancer: The Memorial Sloan Kettering Cancer Center ExperienceShaheen R Alanee, Brett S Carver, Darren R Feldman, et al.
The Journal of Urology|February 14, 2007
Incidence of disease outside modified retroperitoneal lymph node dissection templates in clinical stage I or IIA nonseminomatous germ cell testicular cancerScott E Eggener, Brett S Carver, David S Sharp, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2007
Incidence of metastatic nonseminomatous germ cell tumor outside the boundaries of a modified postchemotherapy retroperitoneal lymph node dissectionBrett S Carver, Bobby Shayegan, Scott Eggener, et al.
BJU International|March 8, 2012
Impact of age on clinicopathological outcomes and recurrence-free survival after the surgical management of nonseminomatous germ cell tumourTimothy A Masterson, Brett S Carver, E Jason Abel, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|May 24, 2008
Association between sarcoidosis and testicular carcinoma: a diagnostic pitfallPhilippe Paparel, Marian Devonec, Paul Perrin, et al.
Pageof 12

Showing results (41-50 of 115) with videos related to

Sort By:
Pageof 12
The Journal of Urology|July 9, 2016
Retroperitoneal Lymph Node Dissection: Anatomical and Technical Considerations from a Cadaveric StudyTyler S Beveridge, Brian L Allman, Marjorie Johnson, et al.
The Journal of Urology|July 12, 2005
Retroperitoneal lymph node dissection in patients with low stage testicular cancer with embryonal carcinoma predominance and/or lymphovascular invasionAndrew J Stephenson, George J Bosl, Dean F Bajorin, et al.
Urology|October 11, 2003
Reoperative retroperitoneal surgery for nonseminomatous germ cell tumor: clinical presentation, patterns of recurrence, and outcomeJames M McKiernan, Robert J Motzer, Dean F Bajorin, et al.
Cancer|December 21, 2006
Pathologic findings and clinical outcome of patients undergoing retroperitoneal lymph node dissection after multiple chemotherapy regimens for metastatic testicular germ cell tumorsScott E Eggener, Brett S Carver, Stacy Loeb, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 20, 2005
Etoposide and cisplatin chemotherapy for metastatic good-risk germ cell tumorsG Varuni Kondagunta, Jennifer Bacik, Dean Bajorin, et al.
Urology|May 29, 2016
Pelvic Lymph Node Dissection in Patients Treated for Testis Cancer: The Memorial Sloan Kettering Cancer Center ExperienceShaheen R Alanee, Brett S Carver, Darren R Feldman, et al.
The Journal of Urology|February 14, 2007
Incidence of disease outside modified retroperitoneal lymph node dissection templates in clinical stage I or IIA nonseminomatous germ cell testicular cancerScott E Eggener, Brett S Carver, David S Sharp, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2007
Incidence of metastatic nonseminomatous germ cell tumor outside the boundaries of a modified postchemotherapy retroperitoneal lymph node dissectionBrett S Carver, Bobby Shayegan, Scott Eggener, et al.
BJU International|March 8, 2012
Impact of age on clinicopathological outcomes and recurrence-free survival after the surgical management of nonseminomatous germ cell tumourTimothy A Masterson, Brett S Carver, E Jason Abel, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|May 24, 2008
Association between sarcoidosis and testicular carcinoma: a diagnostic pitfallPhilippe Paparel, Marian Devonec, Paul Perrin, et al.
Pageof 12